B-Temia’s Exoskeleton Gains Taiwanese Approval

Canadian robotics developer B-Temia has received marketing clearance from Taiwan’s Food and Drug Administration for its Keeogo Dermoskeleton system, a device that supports stroke patients in walking.

The robotic exoskeleton is powered by the patient’s lower limbs and uses sensors to detect movement and software that activates motors to support movement.

The device recently received a 510(k) clearance from the U.S. FDA for assisting stroke patients who experience gait deficits. It is intended for use in rehabilitation settings under the supervision of a trained healthcare professional.